Cargando…

Highly effective NK cells are associated with good prognosis in patients with metastatic prostate cancer

Clinical outcome of patients with metastatic prostate cancer (mPC) at diagnosis is heterogeneous and unpredictable; thus alternative treatments such as immunotherapy are investigated. We retrospectively analyzed natural killer (NK) cells by flow cytometry in peripheral blood from 39 mPC patients, wi...

Descripción completa

Detalles Bibliográficos
Autores principales:	Pasero, Christine, Gravis, Gwenaëlle, Granjeaud, Samuel, Guerin, Mathilde, Thomassin-Piana, Jeanne, Rocchi, Palma, Salem, Naji, Walz, Jochen, Moretta, Alessandro, Olive, Daniel
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Impact Journals LLC 2015
Materias:	Research Paper
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4546472/ https://www.ncbi.nlm.nih.gov/pubmed/25961317

Ejemplares similares

Major response with sorafenib in advanced renal cell carcinoma after 14 years of follow-up
por: Guerin, Mathilde, et al.
Publicado: (2013)

Vitiligo Adverse Event Observed in a Patient With Durable Complete Response After Nivolumab for Metastatic Renal Cell Carcinoma
por: Billon, Emilien, et al.
Publicado: (2019)

Long-term efficacy of crizotinib in a metastatic papillary renal carcinoma with MET amplification: a case report and literature review
por: Rochigneux, Philippe, et al.
Publicado: (2018)

Durable disease control and refractory bullous pemphigoid after immune checkpoint inhibitor discontinuation in metastatic renal cell carcinoma: A case report
por: Mari, Roxane, et al.
Publicado: (2022)

Endoscopic Ultrasound-Guided Radiofrequency Ablation as an Future Alternative to Pancreatectomy for Pancreatic Metastases from Renal Cell Carcinoma: A Prospective Study
por: Chanez, Brice, et al.
Publicado: (2021)

Buccodental side effects of sunitinib in patients with metastatic renal cell carcinoma
por: Gilabert, M, et al.
Publicado: (2013)

Soluble BTN2A1 Is a Potential Prognosis Biomarker in Pre-Treated Advanced Renal Cell Carcinoma
por: Billon, Emilien, et al.
Publicado: (2021)

Systemic treatment for metastatic prostate cancer
por: Gravis, Gwenaelle
Publicado: (2019)

Gastrointestinal Metastases From Primary Renal Cell Cancer: A Single Center Review
por: Rony, Maelle, et al.
Publicado: (2021)

Corrigendum: Gastrointestinal Metastases From Primary Renal Cell Cancer: A Single Center Review
por: Rony, Maelle, et al.
Publicado: (2021)

Impact of active surveillance for prostate cancer on the risk of depression and anxiety
por: Sypre, Davidson, et al.
Publicado: (2022)

Molecular Profiles of Advanced Urological Cancers in the PERMED-01 Precision Medicine Clinical Trial
por: Billon, Emilien, et al.
Publicado: (2022)

Increased NK Cell Maturation in Patients with Acute Myeloid Leukemia
por: Chretien, Anne-Sophie, et al.
Publicado: (2015)

NKG2C(+) memory-like NK cells contribute to the control of HIV viremia during primary infection: Optiprim-ANRS 147
por: Gondois-Rey, Françoise, et al.
Publicado: (2017)

Isolated renal echinococcosis presenting as a complex renal cyst with initial suspicion of malignancy
por: Eldin, Carole, et al.
Publicado: (2019)

Different effects of NK cells and NK-derived soluble factors on cell lines derived from primary or metastatic pancreatic cancers
por: Fiore, Piera Filomena, et al.
Publicado: (2022)

NK Cells, Tumor Cell Transition, and Tumor Progression in Solid Malignancies: New Hints for NK-Based Immunotherapy?
por: Cantoni, Claudia, et al.
Publicado: (2016)

A non-inferiority randomized phase III trial of standard immunotherapy by checkpoint inhibitors vs. reduced dose intensity in responding patients with metastatic cancer: the MOIO protocol study
por: Gravis, Gwenaelle, et al.
Publicado: (2023)

STATs in NK-Cells: The Good, the Bad, and the Ugly
por: Gotthardt, Dagmar, et al.
Publicado: (2017)

A serum metabolomic fingerprint of bevacizumab and temsirolimus combination as first-line treatment of metastatic renal cell carcinoma
por: Jobard, Elodie, et al.
Publicado: (2015)

Human NK Cell Subsets Redistribution in Pathological Conditions: A Role for CCR7 Receptor
por: Pesce, Silvia, et al.
Publicado: (2016)

KRAS Mutational Regression Is Associated With Oligo-Metastatic Status and Good Prognosis in Metastatic Colorectal Cancer
por: Ottaiano, Alessandro, et al.
Publicado: (2021)

Melanoma immunoediting by NK cells
por: Balsamo, Mirna, et al.
Publicado: (2012)

Long-term complete remission with Ipilimumab in metastatic castrate-resistant prostate cancer: case report of two patients
por: Cabel, Luc, et al.
Publicado: (2017)

How melanoma cells inactivate NK cells
por: Pietra, Gabriella, et al.
Publicado: (2012)

Activating KIRs and NKG2C in Viral Infections: Toward NK Cell Memory?
por: Della Chiesa, Mariella, et al.
Publicado: (2015)

NK cell marker gene-based model shows good predictive ability in prognosis and response to immunotherapies in hepatocellular carcinoma
por: Li, Juan, et al.
Publicado: (2023)

Repeated Multimodality Ablative Therapies for Oligorecurrent Pulmonary Metastatic Disease
por: Macagno, Alban, et al.
Publicado: (2022)

Susceptibility of Human Melanoma Cells to Autologous Natural Killer (NK) Cell Killing: HLA-Related Effector Mechanisms and Role of Unlicensed NK Cells
por: Carrega, Paolo, et al.
Publicado: (2009)

Exploiting Human NK Cells in Tumor Therapy
por: Vacca, Paola, et al.
Publicado: (2020)

NK Cell Precursors in Human Bone Marrow in Health and Inflammation
por: Bozzano, Federica, et al.
Publicado: (2019)

A Mature NK Profile at the Time of HIV Primary Infection Is Associated with an Early Response to cART
por: Gondois-Rey, Françoise, et al.
Publicado: (2017)

NK Cells and Other Innate Lymphoid Cells in Hematopoietic Stem Cell Transplantation
por: Vacca, Paola, et al.
Publicado: (2016)

Is CIS a Contraindication to Hyperthermic Intravesical Chemotherapy (HIVEC) after BCG-Failure?
por: Anastay, Vassili, et al.
Publicado: (2023)

CD45 Isoform Profile Identifies Natural Killer (NK) Subsets with Differential Activity
por: Krzywinska, Ewelina, et al.
Publicado: (2016)

NK cells and multiple myeloma-associated endothelial cells: molecular interactions and influence of IL-27
por: Dondero, Alessandra, et al.
Publicado: (2017)

Human Dendritic Cells Activate Resting Natural Killer (NK) Cells and Are Recognized via the NKp30 Receptor by Activated NK Cells
por: Ferlazzo, Guido, et al.
Publicado: (2002)

Human NK Cells: From Surface Receptors to the Therapy of Leukemias and Solid Tumors
por: Moretta, Lorenzo, et al.
Publicado: (2014)

Positive or close margins: reoperation rate and second conservative resection or total mastectomy?
por: Houvenaeghel, Gilles, et al.
Publicado: (2019)

Heterogeneity of NK Cells and Other Innate Lymphoid Cells in Human and Murine Decidua
por: Vacca, Paola, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_kgrq1vr1v6dj3qfsh98874pk9g